Glioblastoma chemotherapeutic agents used in the clinical setting and in clinical trials: Nanomedicine approaches to improve their efficacy

詳細情報 詳細情報について

• CRID

  1360294648097669760

• DOI

  10.1016/j.ijpharm.2020.119283

• ISSN

  03785173

• Web Site

  https://api.elsevier.com/content/article/PII:S0378517320302672?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S0378517320302672?httpAccept=text/plain

• データソース種別

  • Crossref